| Literature DB >> 34001677 |
Priscila Viana Carapeto1, Cristina Aguayo-Mazzucato1.
Abstract
The natural aging process is carried out by a progressive loss of homeostasis leading to a functional decline in cells and tissues. The accumulation of these changes stem from a multifactorial process on which both external (environmental and social) and internal (genetic and biological) risk factors contribute to the development of adult chronic diseases, including type 2 diabetes mellitus (T2D). Strategies that can slow cellular aging include changes in diet, lifestyle and drugs that modulate intracellular signaling. Exercise is a promising lifestyle intervention that has shown antiaging effects by extending lifespan and healthspan through decreasing the nine hallmarks of aging and age-associated inflammation. Herein, we review the effects of exercise to attenuate aging from a clinical to a cellular level, listing its effects upon various tissues and systems as well as its capacity to reverse many of the hallmarks of aging. Additionally, we suggest AMPK as a central regulator of the cellular effects of exercise due to its integrative effects in different tissues. These concepts are especially relevant in the setting of T2D, where cellular aging is accelerated and exercise can counteract these effects through the reviewed antiaging mechanisms.Entities:
Keywords: AMPK; aging; exercise; type 2 diabetes
Mesh:
Substances:
Year: 2021 PMID: 34001677 PMCID: PMC8202894 DOI: 10.18632/aging.203051
Source DB: PubMed Journal: Aging (Albany NY) ISSN: 1945-4589 Impact factor: 5.955
Figure 1Effects of exercise upon the aging process of different organs and systems. Created in BioRender.
Effects of exercise on human and animal models of aging.
| Longevity and healthspan |
Decreased risk of death | [ |
| Cardiopulmonary |
Improved maximal oxygen uptake (↑VO2 max) Improved atherosclerotic plaque composition (calcification only) Prevention of post-MI complications Improved functional outcome in patients with heart failure with preserved ejection fraction Improved progenitor cell functional capacity Decreased endothelial oxidative stress, improves vascular endothelial function Increased hematopoietic stem cells | [ |
| Muscle/bone/skin |
Prevention of age-associated muscle degeneration Reduced physical disability Reduced sarcopenia Improved muscle endurance Enhanced balance and motor coordination Improved skin structure Increased bone formation, decrease osteoporosis | [ |
| Peripheral and central nervous systems |
Improved executive function and memory Prevention of Alzheimer disease and other neurodegenerative diseases Improved neurogenesis, neurotrophins, growth factors and synaptic markers Decreased inflammation Restoration of retinal ganglion cells Preservation of neuromuscular junctions Relaxation, decreased anxiety and depression | [ |
| Metabolism and glucose control |
Decrease peripheral insulin resistance Decreased insulin secretion Increased glucagon, gluconeogenesis and fatty acid metabolism Decreased A1c Increased insulin-independent glucose uptake | Reviewed in [ |
Figure 2AMPK as an effector node on the effects of exercise upon the different hallmarks of aging. AMP, adenosine monophosphate; AMPK, AMP- activated protein kinase; ATP, adenosine triphosphate; AGEs, advanced glycation end-products; FoxO3, Forkhead Box O3; LKB1, Liver kinase B1; mTOR, mammalian target of rapamycin; mTORC1, mTOR complex 1; NAD+, Nicotinamide adenine dinucleotide; NADH, Reduced Nicotinamide adenine dinucleotide; NFkB, Nuclear Factor kappa-light-chain-enhancer of activated B cells; NRF2, Nuclear factor erythroid 2-Related Factor 2; p53, Tumor suppressor protein 53; PGC-1, peroxisome proliferator-activated receptor gamma; SIRT1, Silent information regulator. Created in BioRender.
Figure 3Exercise activated pathways in muscle capable of contributing to improved metabolic control in T2D. AMP, adenosine monophosphate; AMPK, AMP- activated protein kinase; ATP, adenosine triphosphate; Ca2+, divalent cation calcium; CaMKs, calcium/calmodulin dependent protein kinases; GLUT4, glucose transporter type 4; LKB1, liver kinase B1; PGC-1, peroxisome proliferator-activated receptor gamma; ROS, reactive oxygen species. Created in BioRender.
Figure 4Conceptual overview. Created in BioRender.